ClinicalTrials.Veeva

Menu

Study of Treatment of Lisfranc Injuries

T

Tampere University Hospital

Status

Terminated

Conditions

Foot Injury

Treatments

Procedure: Conservative treatment
Procedure: Primary arthrodesis
Procedure: Open reduction and internal fixation

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This trial is designed to compare different treatments on Lisfranc fractures. The trial consist of 2 different strata. Stratum 1: In mild injuries the comparison is between conservative treatment and operative treatment with open reduction and internal fixation (ORIF). Stratum 2: In severe injuries the comparison is between operative treatment with open reduction and internal fixation (ORIF) and primary arthrodesis. The primary outcome measure will be AOFAS Midfoot Score, and secondary outcome measure will be VAS Foot and Ankle.

Full description

The aim of this study is to find out the most effective way to treat Lisfranc injuries

Enrollment

69 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Stratum 1:

  • Nondislocated fractures affecting tarsometatarsal (TMT) joints II and III
  • Dislocation <5mm between medial cuneiforme and base of II metatarsal (MT)
  • No fractures affecting TMT joints IV and V

Stratum 2:

  • Affected joints TMT II- III + any other TMT
  • Any dislocation >2mm (fracture or TMT joint)
  • Dislocation >5mm between medial cuneiforme and base of II MT

Exclusion criteria

  • Open fractures
  • Extra-articular metatarsal (MT) fractures
  • Extremely comminuted fractures with bone loss, and slight chance of gaining proper reduction with screws
  • Patients with multiple fractures
  • Patients with weak co-operation (dementia, alcohol use, etc.)
  • Patients with significant neuropathy or some other neurological condition, diabetes and rheumatoid arthritis
  • Patients with severe circulatory disorder of the lower limb
  • Injuries over 14 days
  • Patients with previous foot injury or surgery
  • Pregnancy
  • Patients who refuse to participate

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

69 participants in 3 patient groups

Open reduction and internal fixation
Active Comparator group
Description:
After operative treatment non-weightbearing cast immobilisation for 6 weeks. Cast will be changed after 2 weeks. After the 6 weeks cast will be replaced with orthotics. Orthotics will remain for 4 weeks.
Treatment:
Procedure: Open reduction and internal fixation
Primary Arthrodesis
Active Comparator group
Description:
After operative treatment non-weightbearing cast immobilisation for 6 weeks. Cast will be changed after 2 weeks. After the 6 weeks cast will be replaced with orthotics. Orthotics will remain for 4 weeks.
Treatment:
Procedure: Primary arthrodesis
Conservative treatment
Active Comparator group
Description:
Non-weightbearing cast immobilisation for 6 weeks. Cast will be changed after 2 weeks. After the 6 weeks cast will be replaced with orthotics. Orthotics will remain for 4 weeks.
Treatment:
Procedure: Conservative treatment

Trial contacts and locations

1

Loading...

Central trial contact

Heidi Haapasalo, MD; PhD; Ville Ponkilainen, BM

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems